Related Experiment Video
Updated: May 22, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients
Hassan Argani1, Amir Ghorbanihaghjo, Ghodratollah Panahi
1Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Objective:
The aim of the present study was to evaluate of Fetuin-A and Pentraxin3 (PTX3) as the main factors for vascular calcification and inflammation in hemodialysis (HD) and renal transplant (RT) patients.
Method:
Serum was obtained from 45 stable chronic HD patients and 44 stable RT recipients. Biochemical factors, intact Parathormone, high-sensitive C-reactive protein (hsCRP), Fetuin-A and PTX3 levels were determined by standard methods.
Results:
In the RT recipients PTX3 level was significantly higher than the HD patients [5.78(1.09-20.36) ng/mL vs. 1.65(0.24-7.89) ng/mL, p ≤ 0.001]. Serum Fetuin-A concentration was significantly higher in the HD compared to RT group [43.39(27.75-81.48) ng/mL vs. 38.76(22.26-89.07) ng/mL, p=0.020]. hsCRP level was also higher in the HD than the RT group [2.90(0.1-8.50) mg/L vs. 1.1(0.1-7.9) mg/L, p=0.003].
Conclusion:
Although our study shows that serum PTX3 is increased and Fetuin-A is decreased after successful RT, their direct role on atherosclerosis needs further studies in the future.
Related Concept Videos
Serum Studies: Renal Function Tests
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Kidney Transplant III: Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant I: Introduction
